An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology

Medicine & Life Sciences

• Receptor Activity-Modifying Proteins 100%
• Calcitonin Receptors 80%
• Pharmacology 38%
• G-Protein-Coupled Receptors 31%
• Islet Amyloid Polypeptide 14%
• Calcitonin Gene-Related Peptide 12%
• Proteins 9%
• Receptor Activity-Modifying Protein 1 9%
• Calcitonin 6%
• Mutation 5%
• Molecular Dynamics Simulation 5%
• GTP-Binding Proteins 5%
• Mutagenesis 5%
• Peptides 3%

Chemistry

• Calcitonin 61%
• Protein 23%
• Amylin 12%
• Mutation 6%
• Ligand 5%
• Agonist 3%
• Molecular Modeling 3%
• Molecular Dynamics 2%
• Simulation 2%
• Peptide 2%